Join a Clinical Study for Chronic Rhinosinusitis with Nasal Polyps

If you’re struggling with chronic rhinosinusitis with nasal polyps (CRSwNP) and have tried other treatments without success, you may be eligible for the CEREN-2 Study at Advanced ENT & Allergy. This clinical trial is evaluating an investigational drug to determine its safety and effectiveness in treating CRSwNP.

What is Chronic Rhinosinusitis with Nasal Polyps?

Chronic rhinosinusitis is a persistent condition causing nasal congestion, sinus pressure, loss of smell, and difficulty breathing. Nasal polyps—painless, noncancerous growths in the nasal passages—can worsen symptoms and make treatment challenging.

Why Join the CEREN-2 Study?

This study is designed to help researchers understand if an investigational treatment can provide relief for those suffering from CRSwNP. Participation in this study could contribute to advancing medical research and offer a potential new treatment option for others with similar symptoms.

Who is Eligible?

You may qualify if you:

• Are 18 years or older
• Have ongoing symptoms of chronic rhinosinusitis
• Have tried other treatments but still experience symptoms
• Have been diagnosed with nasal polyps
• Additional eligibility criteria apply—contact us to learn more.

Important Study Information

The investigational study drug is not yet FDA-approved and is still being evaluated for its safety and effectiveness in treating chronic rhinosinusitis with nasal polyps.

How to Participate

If you’re interested in learning more about the study and whether you qualify, contact our study coordinator:

Dori Davis
Advanced ENT & Allergy
ddavis@advancedentandallergy.com
(502) 399-1884 x 80070

Don’t let chronic sinus issues control your life—explore your options with the CEREN-2 Study today!